BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27104676)

  • 1. Evaluation on the inhibition of pyrrol-2-yl ethanone derivatives to lactate dehydrogenase and anticancer activities.
    Lu NN; Weng ZY; Chen QY; Boison D; Xiao XX; Gao J
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Aug; 165():21-25. PubMed ID: 27104676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, cytotoxicity for mimics of catalase: inhibitors of lactate dehydrogenase and hypoxia inducible factor.
    Xue JJ; Chen QY; Kong MY; Zhu CY; Gen ZR; Wang ZL
    Eur J Med Chem; 2014 Jun; 80():1-7. PubMed ID: 24763359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells.
    Granchi C; Roy S; Giacomelli C; Macchia M; Tuccinardi T; Martinelli A; Lanza M; Betti L; Giannaccini G; Lucacchini A; Funel N; León LG; Giovannetti E; Peters GJ; Palchaudhuri R; Calvaresi EC; Hergenrother PJ; Minutolo F
    J Med Chem; 2011 Mar; 54(6):1599-612. PubMed ID: 21332213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the Saffron Derivative Crocetin as an Inhibitor of Human Lactate Dehydrogenase 5 in the Antiglycolytic Approach against Cancer.
    Granchi C; Fortunato S; Meini S; Rizzolio F; Caligiuri I; Tuccinardi T; Lee HY; Hergenrother PJ; Minutolo F
    J Agric Food Chem; 2017 Jul; 65(28):5639-5649. PubMed ID: 28643510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactivity-guided identification and cell signaling technology to delineate the lactate dehydrogenase A inhibition effects of Spatholobus suberectus on breast cancer.
    Wang Z; Wang D; Han S; Wang N; Mo F; Loo TY; Shen J; Huang H; Chen J
    PLoS One; 2013; 8(2):e56631. PubMed ID: 23457597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting cancer metabolism to develop human lactate dehydrogenase (hLDH)5 inhibitors.
    Zhang SL; He Y; Tam KY
    Drug Discov Today; 2018 Jul; 23(7):1407-1415. PubMed ID: 29750903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual targeting of the Warburg effect with a glucose-conjugated lactate dehydrogenase inhibitor.
    Calvaresi EC; Granchi C; Tuccinardi T; Di Bussolo V; Huigens RW; Lee HY; Palchaudhuri R; Macchia M; Martinelli A; Minutolo F; Hergenrother PJ
    Chembiochem; 2013 Nov; 14(17):2263-7. PubMed ID: 24174263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When will small molecule lactate dehydrogenase inhibitors realize their potential in the cancer clinic?
    Rani R; Kumar V
    Future Med Chem; 2017 Jul; 9(11):1113-1115. PubMed ID: 28722474
    [No Abstract]   [Full Text] [Related]  

  • 9. On-target inhibition of tumor fermentative glycolysis as visualized by hyperpolarized pyruvate.
    Seth P; Grant A; Tang J; Vinogradov E; Wang X; Lenkinski R; Sukhatme VP
    Neoplasia; 2011 Jan; 13(1):60-71. PubMed ID: 21245941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structures of lactate dehydrogenase A (LDHA) in apo, ternary and inhibitor-bound forms.
    Kolappan S; Shen DL; Mosi R; Sun J; McEachern EJ; Vocadlo DJ; Craig L
    Acta Crystallogr D Biol Crystallogr; 2015 Feb; 71(Pt 2):185-95. PubMed ID: 25664730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer-aided discovery and biological characterization of human lactate dehydrogenase 5 inhibitors with anti-osteosarcoma activity.
    Cao W; Fang L; Teng S; Chen H; Wang Z
    Bioorg Med Chem Lett; 2018 Jul; 28(13):2229-2233. PubMed ID: 29861142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the differential action on cancer cells of LDH-A inhibitors based on the N-hydroxyindole-2-carboxylate (NHI) and malonic (Mal) scaffolds.
    Granchi C; Calvaresi EC; Tuccinardi T; Paterni I; Macchia M; Martinelli A; Hergenrother PJ; Minutolo F
    Org Biomol Chem; 2013 Oct; 11(38):6588-96. PubMed ID: 23986182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Hydroxyindole-based inhibitors of lactate dehydrogenase against cancer cell proliferation.
    Granchi C; Roy S; De Simone A; Salvetti I; Tuccinardi T; Martinelli A; Macchia M; Lanza M; Betti L; Giannaccini G; Lucacchini A; Giovannetti E; Sciarrillo R; Peters GJ; Minutolo F
    Eur J Med Chem; 2011 Nov; 46(11):5398-407. PubMed ID: 21944286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactate dehydrogenase inhibition affects homologous recombination repair independently of cell metabolic asset; implications for anticancer treatment.
    Balboni A; Govoni M; Rossi V; Roberti M; Cavalli A; Di Stefano G; Manerba M
    Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129760. PubMed ID: 33035602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a potent inhibitor targeting human lactate dehydrogenase A and its metabolic modulation for cancer cell line.
    Chen CY; Feng Y; Chen JY; Deng H
    Bioorg Med Chem Lett; 2016 Jan; 26(1):72-5. PubMed ID: 26597536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of N-acylhydrazone derivatives as novel lactate dehydrogenase A inhibitors.
    Rupiani S; Buonfiglio R; Manerba M; Di Ianni L; Vettraino M; Giacomini E; Masetti M; Falchi F; Di Stefano G; Roberti M; Recanatini M
    Eur J Med Chem; 2015 Aug; 101():63-70. PubMed ID: 26114812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the suppression of lactate dehydrogenase A on the growth and invasion of human gastric cancer cells.
    Liu X; Yang Z; Chen Z; Chen R; Zhao D; Zhou Y; Qiao L
    Oncol Rep; 2015 Jan; 33(1):157-62. PubMed ID: 25394466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of lactate dehydrogenase activity as an approach to cancer therapy.
    Fiume L; Manerba M; Vettraino M; Di Stefano G
    Future Med Chem; 2014 Mar; 6(4):429-45. PubMed ID: 24635523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragment growing and linking lead to novel nanomolar lactate dehydrogenase inhibitors.
    Kohlmann A; Zech SG; Li F; Zhou T; Squillace RM; Commodore L; Greenfield MT; Lu X; Miller DP; Huang WS; Qi J; Thomas RM; Wang Y; Zhang S; Dodd R; Liu S; Xu R; Xu Y; Miret JJ; Rivera V; Clackson T; Shakespeare WC; Zhu X; Dalgarno DC
    J Med Chem; 2013 Feb; 56(3):1023-40. PubMed ID: 23302067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function.
    Rajeshkumar NV; Dutta P; Yabuuchi S; de Wilde RF; Martinez GV; Le A; Kamphorst JJ; Rabinowitz JD; Jain SK; Hidalgo M; Dang CV; Gillies RJ; Maitra A
    Cancer Res; 2015 Aug; 75(16):3355-64. PubMed ID: 26113084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.